Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04313166
What this trial is testing

Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

Who this might be right for
Amyotrophic Lateral Sclerosis
Collaborative Medicinal Development Pty Limited 55
Post-approval studies (Phase 4)Looking for participantsNCT05923905
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

Who this might be right for
Sporadic and Familial Amyotrophic Lateral Sclerosis
Peking University Third Hospital 64
Not applicableActive Not RecruitingNCT06834269
What this trial is testing

Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Campus Bio-Medico University 60
Not applicableActive Not RecruitingNCT05095571
What this trial is testing

A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Haukeland University Hospital 300
Not applicableStudy completedNCT06165172
What this trial is testing

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 5
Large-scale testing (Phase 3)Study completedNCT01285583
What this trial is testing

Safety Extension Study of TRO19622 in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Hoffmann-La Roche 271
Testing effectiveness (Phase 2)Study completedNCT03204500
What this trial is testing

Dual Treatment With Lithium and Valproate in ALS.

Who this might be right for
Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis, Sporadic
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 43
Testing effectiveness (Phase 2)Study completedNCT04245709
What this trial is testing

Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Dwight Koeberl, M.D., Ph.D. 25
Not applicableNo Longer AvailableNCT06069934
What this trial is testing

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Who this might be right for
Amyotrophic Lateral Sclerosis
Prilenia
Testing effectiveness (Phase 2)Study completedNCT00005766
What this trial is testing

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
National Center for Research Resources (NCRR)
Not applicableStudy completedNCT02645461
What this trial is testing

Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Roma La Sapienza 50
Not applicableUnknownNCT03088839
What this trial is testing

Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Neuromed IRCCS 60
Not applicableActive Not RecruitingNCT01508962
What this trial is testing

PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 100
Early research (Phase 1)Not Yet RecruitingNCT04667013
What this trial is testing

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

Who this might be right for
Healthy
Guangzhou Magpie Pharmaceuticals Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT07095712
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
n-Lorem Foundation 1
Not applicableUnknownNCT03573466
What this trial is testing

Presymptomatic Neuromuscular Junction Defects and Compensatory Mechanisms in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 10
Not applicableLooking for participantsNCT07224256
What this trial is testing

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

Who this might be right for
Tetraplegia/TetraparesisQuadriplegiaCervical Spinal Cord Injury+4 more
Neuralink Corp 6
Not applicableUnknownNCT04809675
What this trial is testing

Effectiveness of Two Oral Appliances for Managing Oral Self-biting Injuries in Patients With ALS

Who this might be right for
Satisfaction
University of Barcelona 31
Not applicableStudy completedNCT00714805
What this trial is testing

Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Christine Barr 41
Not applicableUnknownNCT05358431
What this trial is testing

Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 120
Next Page